Juby Jacob-Nara

Nov 1, 2023 | openres.ersjournals.com | Juby Jacob-Nara |Christian Domingo |Klaus F Rabe |David Price

IntroductionOral corticosteroids (OCS) are commonly used for asthma management, particularly in patients with severe or uncontrolled disease [1]. However, OCS use is associated with increased risk of both acute adverse events and chronic adverse effects, including metabolic, bone- and muscle-related, cardiovascular and psychiatric complications [2, 3].